Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered Twice Daily Orally to Healthy Human Subjects
Clinical trial NCT02211144 · COMPLETED
Trial details
- NCT number
- NCT02211144
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
- Primary completion
- 2002-11-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.